Table 2.
Current Guidelines for Monitoring Response to Therapy in Breast Cancer Patients
| Baseline prior to new therapy | Chemotherapy | Endocrine Therapy | Restaging if concern for progression | |
|---|---|---|---|---|
| Symptom Assessment | Yes | Prior to each cycle | Every 2-3 months | Yes |
| Physical Exam | Yes | Prior to each cycle | Every 2-3 months | Yes |
| Performance Status | Yes | Prior to each cycle | Every 2-3 months | Yes |
| Weight | Yes | Prior to each cycle | Every 2-3 months | Yes |
| LFTs, CBC | Yes | Prior to each cycle | Every 2-3 months | Yes |
| CT scan chest/abd/pelvis | Yes | Every 2-4 cycles | Every 2-6 months | Yes |
| Bone Scan | Yes | Every 2-4 cycles | Every 4-6 months | Yes |
| PET/CT | Optional | Unknown | Unknown | Optional |
*Adapted from NCCN Guidelines 3.2013